1. Critical path initiative - FDA's critical path initiative;US Food and Drug Administration,2004
2. Qualification of novel methodologies for drug development: guidance to applicants;European Medicines Agency,2014
3. PMDA record of the consultation on pharmacogenomics/biomarkers;Japan Pharmaceuticals and Medical Devices Agency,2010
4. Biomarker Qualification Program n.d.. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopmentToolsQualificationProgram/BiomarkerQualificationProgram/ucm20086360.htm [Accessed 20 February 2017].
5. Building a roadmap to biomarker qualification: challenges and opportunities;Amur;Biomarkers Med,2015